Oncology Therapy Market is expected to reach US$ 440.26 billion by 2033 | Top key players - Amgen Inc., AstraZeneca, Bayer AG.

Market Size and Growth:

The Global Oncology Therapy Market size reached US$ 193.98 billion in 2024 and is expected to reach US$ 440.26 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025-2033.

Oncology Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/oncology-therapy-market?sz

The Oncology Therapy Market encompasses treatments, drugs, and technologies designed to prevent, diagnose, and treat various types of cancer. It includes chemotherapy, immunotherapy, targeted therapy, radiation, and surgical approaches. Driven by rising cancer prevalence, advancements in biotechnology, and personalized medicine, the market plays a critical role in improving patient survival rates and enhancing quality of life.

Recent Key Developments of USA and Japan:

USA (Last 3 Months: June - August 2025)

June 23, 2025: Accelerated approval of datopotamab deruxtecan-dlnk for adults with locally advanced or metastatic non-small cell lung cancer with EGFR-mutated tumors.

July 2, 2025: Accelerated approval of linvoseltamab-gcpt for relapsed or refractory multiple myeloma.

Japan (Last 3 Months: June - August 2025)

June 24, 2025: The Japanese Ministry of Health, Labour and Welfare approved Sarclisa in combination with VRd for newly diagnosed multiple myeloma.

August 2025: The National Cancer Center Japan and partners received approval for HemeSight, a comprehensive genomic profiling assay for hematological malignancies.

Market Key Players:

Amgen Inc.
AstraZeneca
Bayer AG
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Novartis AG
GSK plc
Eli Lilly and Company
Rigel Pharmaceuticals, Inc.

Growth Forecast Projected:

The Global Oncology Therapy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Oncology Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=oncology-therapy-market

Market Segmentation:

By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, Others.

By Application: Breast Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, Liver Cancer, Esophageal Cancer, Cervical Cancer, Ovarian Cancer, Bladder Cancer, Head and Neck Cancer, Skin Cancer (Melanoma), Pancreatic Cancer, Kidney Cancer, Others.

By End-User: Hospitals, Cancer Research Centers, Specialty Clinics, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/oncology-therapy-market

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

➠ How big is the Oncology Therapy market?

➠ Who are the key players in the Oncology Therapy market?

➠ What is the projected growth rate of the Oncology Therapy market?

➠ What is the market forecast for the Oncology Therapy industry by 2033?

➠ Which region is estimated to dominate the Oncology Therapy market through the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.